Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Paused · Not applicable

Conditions studied: Critical Limb Ischemia

In brief

The purpose is to demonstrate the safety and effectiveness of the Stellarex DCB for the treatment of stenosis or occlusions of below-the-knee arteries.

Key facts

Study ID
NCT03175744
Run by
Spectranetics Corporation
People needed
82
Starts
2017-05-24
Expected to finish
2025-10-01
Last updated by the study team
2023-06-22

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.